Intervention

albuterol

ClinicalTrials.gov intervention label

Clinical trials9

Recruiting0

Common conditions4

Lead sponsors shown9

Clinical trials

9 shown

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With AsthmaNCT03890666 · 2020-10-26

Repeat Emergency Department Visits Among Patients With Asthma and COPDNCT02499887 · 2016-01-01

Lung Function of Asthmatic Children by Nebulized MgSO4NCT01799109 · 2011-11-01

A Study of LY2216684 in Healthy Participants Receiving Albuterol or PropanololNCT01263197 · 2010-12-01

Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.NCT00588406 · 2007-09-01

Characterization of Placebo Responses in Stable AsthmaNCT01143688 · 2005-01-01

Genetic Determinants of the Bronchodilatation Effect of Albuterol ex-VivoNCT00162422 · 2003-08-01

Symbicort Onset of Action 2NCT00646009 · 2003-03-01

Dose-response of Albuterol in AsthmaticsNCT00940927 · 1993-07-01

Common conditions

Asthma7 Asthma Placebo Effects1 COPD1 Major Depressive Disorder1

Leading sponsors

AstraZeneca1 Brigham and Women's Hospital1 Chongqing Medical University1 Eli Lilly and Company1 Hadassah Medical Organization1 Nemours Children's Clinic1 Northwell Health1 State University of New York at Buffalo1 Teva Branded Pharmaceutical Products R&D, Inc.1

Trial status mix

COMPLETED7

TERMINATED1

UNKNOWN1

Phase mix

NA4

PHASE32

PHASE42

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.